RxDoctor Payments Data

David Harvey, MD

Psychiatry · Palm Springs, CANPI 1467402073

Payments from drug & device makers

$10,601in general payments, 2019–2025

Across 305 payments — averaging $34.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$4K
  • AbbVie$3K
  • Alkermes, Inc.$672
  • Takeda Pharmaceuticals U.S.A., Inc.$468
  • Vanda Pharmaceuticals Inc.$424
  • Otsuka America Pharmaceutical, Inc.$349
  • plus $2K from 15 others

What the payments were for

  • Speaking & faculty fees$5,90356%
  • Food & beverage$4,69944%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,601 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$58,425
Medicare patients
58
Services billed
538

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide40$33,545
Bupropion XlBupropion Hcl57$2,056
Trazodone Hcl79$775
Buspirone Hcl83$712
Zolpidem Tartrate ErZolpidem Tartrate14$707
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine19$682
Alprazolam83$552
Quetiapine Fumarate36$513
Aripiprazole15$469
Sertraline Hcl32$453
Mirtazapine37$439
Zolpidem Tartrate48$409
Escitalopram Oxalate36$399
Duloxetine Hcl22$388
Nortriptyline Hcl16$380

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$468$33,54540 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Palm Springs

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →